TSS:Rfhg 43896.1

Basic information about the TSS

---

TSS ID: rfhg_43896.1 Species: human Chr: chr3		Start: 37175854 End: 37175879 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3414173,EH38E2192308)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000482466.5:-178 GeneID: 9209 HGNC/MGI_ID: HGNC:6703 UniProt_ID: Nearer transcript ids and distances: ENST00000496825.2:-265 ENST00000438374.5:-372 ENST00000490597.5:-423 BC017703:-425 ENST00000440230.5:-429 BC053668:-438 ENST00000483306.2:-448 NR_145514.2:-448 ENST00000421276.6:-458 AK291514:-458 ENST00000354379.8:-481 NM_001348300.1:-481 NM_001348303.1:-481 NM_001348302.1:-481 NM_001348306.1:-481 NM_001348310.1:-481 NM_001348309.1:-481 NM_001348311.1:-481 NM_001348298.1:-481 NM_001348297.1:-481 NM_001348299.1:-481 NM_001348301.1:-481 NM_001348305.1:-481 NM_001134369.2:-481 NM_001348304.1:-481 NM_001348308.1:-481 NM_017724.2:-481 view more...

Gene_name: LRR binding FLII interacting protein 2 Gene_symbol: LRRFIP2 Gene_synonyms: HUFI-2 Gene_source: HGNC:6703

TATA-Box annotation

---

Distance to TSS:	494
Nearest PromoterID:	NM_017724
Entrez ID:	9209
Nearest Unigene:	Hs.740522
Nearest Refseq:	NM_006309
Nearest Ensembl:	ENSG00000093167
Gene Name:	LRR binding FLII interacting protein 2
Gene Alias:	HUFI-2
Gene Type:	protein-coding
CpG%:	0.120000
GC%:	0.576923
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LRRFIP2 p2@LRRFIP2 p3@LRRFIP2 p4@LRRFIP2 p5@LRRFIP2 p6@LRRFIP2
Sample		p1@LRRFIP2	p2@LRRFIP2	p3@LRRFIP2	p4@LRRFIP2	p5@LRRFIP2	p6@LRRFIP2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	43.44	5.06	0.19	0.58	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	36.42	3.44	0.20	0.20	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.62	4.82	0.00	0.58	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	33.06	3.33	0.21	0.83	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	36.44	5.17	0.00	0.22	0.00	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	37.41	4.46	0.00	0.39	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	58.83	5.01	0.22	0.44	0.87	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	46.51	6.78	0.00	0.00	0.24	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	46.16	3.42	0.00	0.21	0.00	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	70.71	8.69	0.00	0.00	1.16	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	69.93	8.89	0.40	0.00	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	65.05	11.79	0.41	0.41	0.41	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	57.38	4.03	1.13	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	48.71	4.51	0.60	0.15	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	55.77	6.81	1.10	0.00	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	49.04	4.02	0.25	0.75	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	46.30	3.71	0.22	0.00	1.09	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	51.46	1.69	1.69	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	47.45	3.20	0.53	0.00	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	50.70	4.21	0.45	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	46.11	2.27	0.67	0.40	0.53	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	50.75	4.14	0.86	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	43.56	3.49	0.52	0.26	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	46.59	2.91	0.24	0.49	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	51.34	5.42	0.52	0.00	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	47.79	4.75	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	43.96	2.20	1.10	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	44.79	2.83	0.71	0.00	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	37.63	2.58	0.00	0.00	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.79	3.26	1.45	0.00	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	39.98	3.77	0.21	0.00	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	42.40	3.91	0.20	0.00	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	44.95	3.59	0.63	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	40.91	3.79	0.33	0.33	1.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	38.52	5.42	0.93	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	52.50	4.60	0.38	0.00	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	48.44	3.47	0.00	0.61	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	34.66	4.43	0.60	0.20	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	44.30	4.59	0.54	0.00	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	42.73	5.52	0.72	0.00	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.35	3.53	0.24	0.24	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	36.89	2.93	0.29	0.44	1.02	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	41.34	5.69	0.42	0.21	0.63	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	51.22	5.42	1.22	0.52	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	51.40	6.63	0.80	0.00	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	44.90	3.72	0.70	0.00	0.70	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	47.02	6.48	1.20	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	42.62	4.77	0.30	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	47.16	4.55	0.24	0.24	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	44.28	4.45	0.40	0.00	1.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	45.09	5.12	0.61	0.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	46.92	5.11	0.89	0.44	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	363.80	55.97	13.99	13.99	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	41.52	5.68	0.71	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	31.81	3.98	0.99	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	73.83	3.36	0.00	2.52	2.52	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	34.90	3.21	0.00	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	34.68	3.57	0.97	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	35.97	2.25	0.96	0.32	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	35.52	3.14	0.31	0.63	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	2.82	0.71	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	35.33	2.80	0.00	0.00	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	55.73	0.80	0.00	0.00	0.80	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	37.37	3.74	0.00	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	43.86	3.57	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	35.85	3.90	0.00	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	0.00	0.00	16.16	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	284.31	23.69	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	40.95	3.41	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	37.69	1.98	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	32.84	4.22	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	48.35	3.97	0.99	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	52.59	3.40	0.62	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	56.87	3.36	0.31	0.31	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	58.13	4.59	1.27	0.32	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	47.49	5.13	0.32	0.64	0.64	0.00
Adipocyte - omental, donor1	11473-119C6	64.50	5.73	1.53	0.13	0.38	0.13
Adipocyte - omental, donor2	11474-119C7	52.32	6.73	0.75	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	31.48	2.68	0.67	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	56.78	3.83	0.64	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	27.10	2.71	0.00	1.35	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	21.90	0.70	0.00	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	44.20	1.96	0.59	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	37.32	2.06	0.51	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	40.42	3.07	0.56	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	47.61	2.35	0.00	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	45.61	1.29	0.00	0.00	0.32	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	31.63	1.61	0.32	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	31.46	3.73	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	45.07	4.45	0.00	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	20.79	1.25	0.83	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	23.61	0.50	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	25.20	0.65	0.00	0.00	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	26.79	1.52	0.00	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	38.45	1.99	0.00	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	19.72	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	27.89	0.18	0.36	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	18.49	0.82	0.00	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	38.45	0.92	0.11	0.34	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	33.55	1.47	0.00	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	30.10	3.59	0.45	1.80	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	31.69	3.47	0.00	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.98	3.59	0.30	1.20	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	2.53	0.00	5.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	21.78	3.96	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	27.94	3.90	0.65	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.50	5.83	0.00	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.32	1.19	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	32.01	4.14	0.38	1.13	1.51	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	5.81	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	28.84	1.25	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	34.76	2.31	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	27.30	1.36	0.00	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.31	1.51	0.30	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	32.68	4.82	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	31.93	1.89	0.57	0.00	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	37.42	2.94	0.53	0.80	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	29.26	5.85	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	35.16	2.32	0.33	0.33	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	28.82	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	34.82	4.46	0.69	0.34	0.51	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	8.39	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	28.64	5.34	0.97	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.77	3.04	1.14	0.00	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	30.28	0.00	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	29.64	3.99	0.00	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	32.28	2.35	0.00	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	31.75	2.32	0.00	0.52	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	25.81	2.82	0.00	0.94	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	36.98	1.61	0.64	0.32	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	2.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	24.57	0.58	0.00	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	34.62	1.51	0.00	1.20	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	36.83	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	34.58	1.02	1.02	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	30.82	2.29	0.00	0.76	1.02	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.86	3.18	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	31.07	2.16	1.73	0.86	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	28.37	1.69	0.00	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	25.81	3.48	0.00	0.29	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	22.67	4.72	0.94	0.94	0.94	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.12	1.86	0.00	0.34	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	46.33	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	0.00	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	32.16	2.57	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	28.28	5.41	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	27.70	5.83	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.41	3.68	0.46	0.46	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	10.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	36.86	5.85	0.25	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	38.19	3.92	0.00	0.41	0.83	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	30.29	2.75	0.00	0.31	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	31.07	5.26	0.48	0.96	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.70	3.77	0.22	0.22	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	36.62	1.53	0.00	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	34.34	4.43	0.55	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	32.04	2.91	0.26	0.00	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	35.25	3.27	0.73	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	47.65	3.07	0.49	0.25	0.61	0.37
Astrocyte - cerebellum, donor2	11580-120F5	36.46	2.57	0.68	0.17	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	28.74	1.26	0.00	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	54.38	1.74	0.00	0.35	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	66.81	3.56	1.29	0.65	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	63.84	3.43	0.30	0.45	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	48.28	0.57	0.34	1.03	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	55.88	2.76	0.13	0.38	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	52.01	1.14	0.00	0.68	0.11	0.00
Basophils, donor1	12241-129G9	129.20	15.43	1.57	0.00	0.78	1.05
Basophils, donor2	12242-129H1	169.93	22.73	3.61	0.00	0.00	0.00
Basophils, donor3	12243-129H2	113.78	13.38	1.76	0.15	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	27.81	2.16	0.86	0.22	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	21.03	1.83	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	43.31	3.14	0.63	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	41.38	2.91	0.00	0.00	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	52.51	2.30	0.46	0.00	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	37.61	1.26	1.62	0.90	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	40.19	1.65	0.31	0.31	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	68.94	0.93	0.47	0.70	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	70.99	5.44	0.96	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	155.13	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	237.26	38.89	4.51	0.00	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	156.28	26.36	2.97	1.48	1.30	0.19
CD14+ Monocytes, donor3	11381-118B4	198.68	39.96	1.98	0.22	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	61.99	0.85	0.85	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	57.62	0.76	0.38	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	68.38	0.99	0.66	0.00	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	100.03	19.08	1.73	0.58	0.43	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	83.58	11.77	1.21	0.91	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	114.18	24.16	3.08	0.71	0.47	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	107.80	27.45	1.51	0.67	0.50	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	108.20	20.70	2.21	0.55	0.83	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	109.58	29.50	1.49	0.50	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	134.32	31.52	2.15	0.59	0.20	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	128.37	24.39	2.31	0.53	0.89	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	160.39	31.99	3.26	0.65	0.87	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	149.37	45.65	0.70	0.00	0.70	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	149.43	33.79	1.06	1.06	1.06	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	123.14	23.30	2.22	1.11	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	90.74	17.25	0.74	0.74	0.15	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	83.81	12.17	1.60	0.20	0.20	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	95.15	17.07	1.46	1.04	0.21	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	154.20	33.17	2.52	0.69	0.69	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	143.19	28.28	2.71	0.00	0.45	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	133.56	32.30	1.31	0.87	0.87	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	125.35	29.59	1.61	1.88	0.54	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	137.82	28.96	3.14	1.22	0.70	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	150.65	38.29	1.68	2.52	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	209.43	52.73	2.57	2.57	0.73	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	243.06	58.48	1.41	1.06	0.35	2.82
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	232.96	76.78	3.95	0.44	0.88	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	116.48	27.03	0.87	0.87	0.70	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	120.05	24.16	2.60	0.74	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	153.47	26.73	2.59	0.86	0.22	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	190.41	51.60	1.64	1.64	1.23	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	187.06	45.66	1.16	1.85	0.70	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	201.14	54.05	3.25	1.16	1.86	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	43.37	1.96	0.65	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	46.89	4.39	2.54	0.92	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	47.87	4.33	1.08	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	78.95	4.36	1.87	0.47	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	69.86	7.86	2.27	0.00	0.17	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	126.87	11.82	2.23	0.22	0.45	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	44.40	3.06	2.55	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	49.18	2.63	3.51	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	62.32	2.32	3.37	0.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	44.71	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	46.10	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	39.35	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	54.37	2.67	0.53	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	39.67	0.00	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	40.71	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	42.36	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	51.41	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	61.64	0.82	1.64	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	63.84	2.90	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	62.09	0.50	0.00	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	131.32	3.64	7.27	0.40	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	85.89	2.40	3.99	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	89.36	6.02	3.01	0.00	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	130.90	16.85	2.81	0.00	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	65.38	4.88	1.13	0.00	1.13	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	76.44	3.38	1.13	0.23	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	81.05	2.14	1.07	0.00	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	77.16	1.84	1.84	0.61	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	74.72	3.05	0.61	0.61	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	45.43	0.51	1.02	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	48.51	0.45	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	49.73	0.00	0.29	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	50.73	0.00	0.00	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	51.97	0.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	58.96	1.88	1.01	0.43	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	52.53	1.02	0.51	0.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	43.69	0.97	0.48	0.16	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	82.94	7.17	2.24	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	81.41	4.89	1.75	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	79.20	4.40	0.88	1.32	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.06	0.84	2.11	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	42.59	1.45	0.62	0.62	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	42.10	0.67	1.00	0.33	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	38.34	0.27	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	51.45	0.00	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	48.42	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	50.81	1.11	0.37	0.00	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	48.31	1.08	0.22	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	53.80	1.05	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	52.08	0.51	0.51	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	43.76	2.17	0.87	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	51.43	1.74	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.94	0.00	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	48.93	0.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	66.46	1.11	1.38	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	71.41	0.49	0.25	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	66.22	1.54	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	63.03	1.43	1.07	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	54.01	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	77.59	1.64	0.33	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	84.10	3.38	0.38	2.25	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	81.55	1.26	1.51	1.01	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	49.09	6.88	0.23	0.23	0.23	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	47.21	7.43	0.72	1.44	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	48.43	6.57	1.09	0.55	1.37	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	47.73	6.00	0.30	1.20	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	54.24	8.40	0.00	0.48	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	48.66	8.19	0.23	0.23	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.02	6.74	0.22	0.22	0.22	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	56.33	10.00	0.26	0.26	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	59.33	7.27	0.23	0.94	0.47	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	53.73	9.36	0.30	0.30	0.91	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	59.26	7.84	0.29	0.87	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	56.75	7.46	0.27	0.00	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	75.29	17.95	0.00	0.00	1.75	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	95.64	18.67	0.91	0.00	1.82	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	86.52	10.44	1.49	0.00	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	52.94	8.64	0.00	0.36	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	61.57	8.63	0.29	0.00	0.58	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	51.38	8.01	0.00	1.18	0.94	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	51.66	11.09	0.63	0.63	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	67.36	8.61	0.62	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	55.14	8.34	0.32	0.00	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	61.19	6.50	0.38	0.76	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	48.47	7.49	0.00	0.00	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	59.76	6.05	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	107.60	9.64	0.80	0.80	4.01	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	108.41	10.49	1.40	0.00	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	100.18	12.02	2.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	29.24	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	0.99	0.00	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	33.57	1.16	0.00	0.11	0.42	0.00
Chondrocyte - de diff, donor1	11261-116G1	63.79	3.81	0.00	1.73	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	31.27	3.20	0.36	0.00	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	43.12	2.84	0.46	0.80	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	70.73	7.16	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	47.32	0.40	0.40	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	37.76	1.15	0.34	0.34	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	28.22	0.86	0.43	1.07	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	33.89	0.88	0.09	0.27	0.18	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	93.35	3.12	1.56	0.09	0.92	3.67
Corneal Epithelial Cells, donor1	11526-119I5	28.11	2.20	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	39.82	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	45.76	3.58	0.51	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	52.34	7.43	1.16	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	52.04	5.68	0.95	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	72.46	13.80	6.90	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	40.82	5.29	1.40	0.32	0.65	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	53.64	0.68	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	62.68	1.96	1.96	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	64.36	0.97	1.94	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	39.86	4.67	0.67	0.00	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	29.93	5.87	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	47.79	5.09	0.00	0.28	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	51.51	6.29	0.00	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	54.98	11.34	0.58	0.00	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	70.35	10.82	0.24	1.41	0.71	0.94
Endothelial Cells - Artery, donor3	11413-118E9	43.30	3.86	0.53	0.00	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	39.01	0.89	0.66	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	57.81	3.04	0.61	0.00	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	51.31	1.13	0.28	0.28	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	29.12	1.78	0.30	0.00	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	29.16	4.17	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	29.35	1.56	0.14	0.28	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	63.22	7.20	0.00	0.00	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	27.78	2.62	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	94.43	5.96	1.24	0.12	0.50	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	79.52	4.78	0.43	0.43	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	79.99	4.52	0.73	0.24	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	23.89	5.69	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	39.12	3.49	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	48.20	3.14	0.31	0.16	0.31	0.31
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	178.23	11.55	3.30	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	146.24	7.13	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	30.05	1.95	1.47	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	6.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	70.61	6.98	0.41	0.00	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	27.26	4.16	0.22	0.44	0.44	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	50.59	3.36	0.43	0.65	0.33	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	63.55	3.88	0.73	0.24	0.85	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	64.82	7.78	2.87	0.00	0.96	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	48.52	4.75	0.42	1.05	0.32	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	65.35	2.90	2.90	0.53	0.53	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	60.46	5.65	0.33	1.00	0.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	42.64	5.44	0.00	0.91	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	23.50	1.52	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	32.02	3.94	0.32	0.16	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	65.47	3.03	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	56.60	2.92	0.51	0.25	0.38	0.13
Fibroblast - Cardiac, donor6	11460-119B2	59.27	5.15	0.76	0.15	0.45	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	32.96	1.34	0.80	0.13	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.59	1.29	0.00	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	32.23	1.46	0.00	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	94.56	3.92	0.23	0.23	0.46	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	49.52	1.02	0.51	0.68	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	54.23	6.81	0.94	0.70	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	44.34	4.72	0.94	0.00	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	67.45	11.36	0.48	0.85	0.36	0.24
Fibroblast - Dermal, donor4	11450-119A1	143.91	11.64	0.90	1.02	1.13	0.57
Fibroblast - Dermal, donor5	11454-119A5	144.62	13.96	1.05	0.70	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	137.25	13.16	0.49	0.16	1.30	0.49
Fibroblast - Gingival, donor1	11237-116D4	58.51	2.29	1.25	0.00	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	164.54	29.61	3.67	0.00	2.10	0.26
Fibroblast - Gingival, donor2	11318-117D4	79.07	3.69	0.66	0.92	0.40	0.26
Fibroblast - Gingival, donor3	11394-118C8	90.40	3.29	0.77	0.48	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	78.96	5.19	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	70.31	4.58	0.18	1.06	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	117.70	13.56	0.78	0.47	0.94	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	110.35	14.20	0.95	0.68	0.95	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	117.51	21.17	2.12	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	110.71	13.75	0.73	0.58	0.73	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	98.99	10.91	0.55	0.41	0.14	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	153.24	26.33	1.32	1.10	1.32	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	103.60	9.68	1.61	0.44	0.88	0.59
Fibroblast - Lung, donor1	11270-116H1	10.87	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	65.65	2.98	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	44.74	2.32	0.42	0.42	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	59.14	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	27.97	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	18.47	0.56	0.28	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	84.04	3.65	0.41	0.00	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	39.94	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	103.39	7.76	0.58	0.78	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	107.24	7.58	0.30	0.61	0.91	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	136.16	13.16	1.53	0.31	1.22	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	103.04	12.59	0.38	0.00	0.76	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	93.96	15.93	0.27	3.51	1.35	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	71.09	4.18	0.12	0.35	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	39.68	3.09	0.00	0.22	0.55	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	49.58	2.44	0.81	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.08	0.67	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	50.21	3.95	0.79	0.00	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	148.04	30.76	4.37	0.20	0.40	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	78.68	10.12	1.24	0.89	0.89	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	79.23	8.47	0.20	0.59	0.59	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	73.71	9.33	0.30	0.00	0.90	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	111.30	16.19	1.30	0.32	1.08	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	96.42	18.73	2.02	0.00	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	89.42	16.41	0.49	0.16	1.31	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	120.30	16.84	5.81	0.00	1.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	75.45	8.34	0.50	0.20	0.80	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	87.04	6.95	1.81	0.30	1.81	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	91.54	8.53	0.99	0.66	1.57	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	54.70	2.22	0.68	0.17	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	79.48	14.78	3.28	0.00	1.31	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	102.26	15.13	0.85	0.32	0.96	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	72.53	8.10	0.67	0.51	0.84	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	86.88	16.00	0.31	1.25	0.94	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	797.75	22.16	0.00	44.32	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	88.02	16.56	2.61	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	86.68	12.31	0.52	0.35	0.00	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	98.37	10.93	1.04	0.52	0.78	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	95.56	15.59	0.77	0.26	0.00	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	39.04	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	29.99	1.28	0.00	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	53.91	1.71	0.29	0.29	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.81	1.38	0.28	0.55	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	56.85	2.05	0.46	0.23	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	44.18	1.59	0.20	0.99	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	41.76	0.79	0.00	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	64.58	0.98	1.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	56.60	1.33	0.00	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.75	0.57	0.00	0.71	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.54	0.86	0.12	0.74	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	33.04	0.27	0.00	0.27	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	54.88	1.24	0.12	0.37	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	50.25	1.11	0.14	0.83	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	37.20	0.81	0.00	1.02	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	45.86	1.60	0.23	0.00	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.12	0.62	0.37	0.75	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.66	0.87	0.00	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.94	1.77	0.59	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	48.96	2.23	0.16	0.95	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.80	0.89	0.00	0.45	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	49.00	2.82	0.00	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	55.98	2.88	0.17	0.34	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.99	3.01	0.27	0.09	0.44	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	58.79	1.77	0.52	0.21	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.87	1.20	0.51	0.00	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	50.90	1.55	0.44	0.77	0.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.33	2.66	0.17	0.00	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.43	1.84	0.20	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.07	2.27	0.41	0.83	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	47.85	0.92	0.23	1.04	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.19	2.00	0.17	0.67	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	44.31	1.76	0.00	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	45.14	0.37	0.49	0.61	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	44.09	2.59	0.00	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.26	0.64	0.32	0.96	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	39.32	1.14	0.09	0.66	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.39	1.42	0.16	0.79	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.48	0.91	0.30	0.30	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.76	1.46	0.10	0.42	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.71	0.66	0.22	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.15	1.68	0.84	0.28	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	46.94	2.69	0.28	0.74	0.19	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	41.98	5.62	0.27	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	56.61	5.05	0.31	0.15	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	45.47	2.59	0.26	0.13	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	42.83	1.36	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	45.53	1.84	0.00	0.37	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.91	1.10	0.00	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	57.52	2.98	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	49.99	3.30	0.13	0.26	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	44.39	1.41	0.61	0.61	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	56.93	1.27	0.00	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	37.82	0.60	0.00	0.00	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.75	0.46	0.15	0.31	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	45.01	0.20	0.20	0.00	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	32.54	0.63	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	27.13	0.85	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	39.20	0.46	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	56.92	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.52	1.93	0.39	0.39	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	43.32	4.81	0.00	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	45.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	32.22	2.93	0.00	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	48.18	2.47	0.00	0.41	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	41.11	1.68	0.00	0.56	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	47.72	0.98	0.00	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	2.52	0.00	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.44	1.59	0.00	0.00	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	35.32	1.02	0.00	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	42.38	1.15	0.00	1.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.68	0.59	0.00	0.59	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	5.08	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	47.22	3.31	0.00	0.00	0.41	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	40.50	2.30	0.00	0.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	33.83	2.31	0.77	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	33.57	0.65	0.00	0.00	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.12	2.01	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	45.08	0.77	0.00	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	52.72	2.40	0.68	0.34	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	42.47	0.94	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	34.40	2.41	1.21	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.66	0.51	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	41.08	0.80	0.00	0.40	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	38.98	0.99	0.49	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	53.12	2.36	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	41.42	0.58	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.96	0.88	0.00	0.44	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	24.58	2.54	0.00	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	31.04	1.79	0.00	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	29.11	1.46	0.00	0.49	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	33.10	3.42	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	64.87	9.15	2.08	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	43.85	5.62	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	60.58	7.93	0.95	1.27	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	51.80	6.68	1.25	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	41.78	3.13	0.58	0.58	0.12	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	45.24	2.87	0.34	0.34	0.17	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	35.49	2.73	0.00	0.46	0.23	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	39.46	2.73	0.11	0.55	0.11	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	36.11	5.37	0.43	0.86	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	41.12	2.37	0.22	0.00	0.22	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	42.22	3.61	0.25	0.37	0.25	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	35.17	4.63	0.34	0.34	0.17	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.19	2.88	0.32	0.64	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	46.45	5.04	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	22.07	2.60	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	15.86	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.81	0.71	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	23.25	0.73	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	33.74	1.75	0.17	0.35	0.17	0.35
Hepatocyte, donor1	11523-119I2	60.53	6.05	0.00	0.00	0.00	2.42
Hepatocyte, donor2	11603-120I1	71.10	3.23	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	85.90	7.36	1.23	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	62.01	8.48	3.26	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	58.03	3.67	0.35	0.00	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.76	0.69	0.00	0.27	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	3.18	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	0.00	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	42.23	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	0.00	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	35.73	1.32	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	33.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	34.01	0.00	1.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	1.94	1.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	37.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	45.63	0.00	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	25.19	0.84	0.84	0.00	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	35.36	3.21	0.80	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	31.39	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.85	0.47	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.93	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	36.59	1.08	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	33.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.80	1.28	0.64	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	1.82	0.00	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	38.56	0.00	0.71	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	32.10	0.31	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	42.42	0.00	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	48.83	0.00	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	0.00	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	50.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	39.58	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	38.07	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	72.87	12.24	0.41	0.33	0.24	0.49
Keratinocyte - epidermal, donor2	11349-117G8	22.84	2.34	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	72.70	4.35	0.19	0.47	0.28	0.09
Keratinocyte - oral, donor1	11251-116E9	63.91	2.38	0.91	0.34	0.00	0.11
Keratocytes, donor1	11527-119I6	82.86	2.75	1.03	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	35.15	2.34	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	67.18	3.56	0.40	0.40	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	59.34	6.59	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	38.83	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	41.29	0.69	0.23	0.23	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	27.75	1.01	0.00	0.10	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.57	2.73	0.12	0.47	0.59	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	34.88	1.67	0.28	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	45.02	2.52	0.16	0.79	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	30.11	2.69	0.54	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	27.73	2.84	0.00	0.00	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.86	2.05	0.11	0.65	0.43	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.94	6.57	0.41	1.23	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.98	1.52	0.00	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.53	1.83	0.14	1.27	0.99	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	44.70	6.33	0.40	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	40.52	2.71	0.39	0.58	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.85	1.67	0.37	0.19	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	35.19	2.09	0.35	0.35	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	33.15	2.86	0.24	0.00	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	27.33	1.92	0.00	0.27	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	47.73	4.31	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.69	2.18	0.00	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	34.59	1.65	0.18	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	38.84	2.63	0.00	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.09	0.88	0.00	0.00	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	22.90	1.99	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.53	2.42	0.00	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	33.12	1.89	0.27	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.61	5.00	0.30	0.00	0.61	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	33.18	0.00	0.00	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	44.18	3.56	0.63	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	25.26	3.16	0.15	0.45	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	48.84	4.13	0.00	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.49	3.39	0.19	0.75	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.96	2.54	0.11	0.42	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.52	1.45	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.09	3.31	0.00	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.86	2.35	0.00	0.37	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	56.64	4.81	0.00	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	38.30	3.21	0.25	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.50	2.89	0.27	0.14	0.55	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	46.64	3.54	0.00	0.00	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	56.00	4.26	0.30	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	48.57	3.64	0.42	0.28	0.98	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	35.91	2.13	0.00	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	23.75	3.88	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	26.45	2.02	0.16	0.16	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	37.96	1.43	0.00	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	37.24	3.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	20.25	1.41	0.00	0.47	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	42.20	2.48	0.12	0.50	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	27.41	5.38	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	29.54	2.39	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	9.06	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	21.48	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.04	1.48	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	28.77	3.81	1.27	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.88	2.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	4.64	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	2.38	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.62	3.39	1.13	0.45	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.34	3.78	0.58	0.29	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.51	5.40	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.74	3.79	1.35	0.00	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	4.11	2.05	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	28.58	6.70	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.32	6.00	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	20.88	4.08	2.04	1.02	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	34.95	7.74	0.80	0.27	0.00	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	28.15	6.05	1.32	0.94	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	30.06	9.20	1.23	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	4.08	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	30.82	4.58	0.83	0.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	34.47	4.20	0.28	1.68	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	18.55	5.15	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	26.42	6.68	0.87	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	30.79	6.58	0.60	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.22	3.87	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	30.40	2.47	0.35	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.86	7.01	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	4.61	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.96	2.30	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.65	4.53	0.00	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	3.28	1.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	18.08	3.62	0.90	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.75	1.44	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.15	1.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	28.24	2.23	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.71	1.72	1.72	1.29	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	21.41	4.28	2.57	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	24.32	3.33	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.17	3.02	1.21	0.00	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.06	3.55	1.42	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	25.78	3.44	1.37	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	19.32	2.15	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	2.69	1.35	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.97	1.85	1.11	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	34.89	5.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	22.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	19.61	2.40	0.40	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	19.63	4.36	1.45	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.89	5.37	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.14	3.45	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	2.82	0.00	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	4.53	1.51	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	23.43	4.51	1.35	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	3.44	1.72	0.00	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	24.05	4.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	24.63	5.08	1.17	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	3.30	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.21	3.11	2.08	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	22.75	7.00	3.06	0.00	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	33.55	6.15	0.56	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.73	7.51	2.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	19.67	3.86	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	27.34	9.62	0.51	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.55	5.77	0.96	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.07	3.98	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	27.34	6.08	0.61	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.28	1.38	0.00	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	30.02	5.32	1.14	0.00	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.11	5.68	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.77	3.02	0.60	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	22.18	2.54	0.95	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	25.06	5.86	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	18.39	1.72	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.71	3.60	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.22	3.54	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	15.32	0.57	1.70	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	17.89	2.91	1.25	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	3.13	0.78	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.13	3.76	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	29.27	2.32	0.93	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	23.42	2.68	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.06	2.67	1.07	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	27.07	2.42	0.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	4.59	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	2.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.93	1.71	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	2.30	1.53	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	28.45	2.19	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.93	2.67	1.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	24.44	4.16	0.78	0.52	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	2.65	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	41.71	1.37	0.68	0.00	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	37.62	2.02	0.55	0.18	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	42.86	2.36	0.26	0.39	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	47.26	11.68	2.12	0.00	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	67.66	10.46	0.48	0.48	0.16	0.95
Mallassez-derived cells, donor3	11930-125I4	84.37	15.43	0.69	0.42	0.14	0.56
Mammary Epithelial Cell, donor1	11273-116H4	119.77	18.73	1.59	0.60	0.20	0.70
Mammary Epithelial Cell, donor2	11350-117G9	92.37	13.32	0.58	2.32	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	53.63	4.99	0.75	0.25	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	190.50	24.41	2.03	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	73.75	2.05	0.32	0.11	0.22	0.11
Mast cell, donor2	11565-120D8	193.46	9.51	2.38	1.19	0.89	2.67
Mast cell, donor3	11566-120D9	172.67	5.40	2.48	0.45	1.13	1.13
Mast cell, donor4	11567-120E1	146.09	5.14	2.84	0.18	0.71	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	66.54	2.77	0.11	0.22	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	77.05	4.67	0.58	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	62.64	1.61	0.00	0.11	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	95.23	4.35	1.00	0.17	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	41.29	1.09	0.40	0.00	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	30.11	0.69	0.35	0.35	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	54.33	1.96	0.00	0.14	0.36	0.07
Melanocyte - light, donor1	11274-116H5	26.56	1.18	0.24	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	9.55	1.36	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	18.21	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	50.19	2.29	0.10	0.42	0.00	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	59.97	10.22	1.08	0.54	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	54.64	4.29	0.27	0.80	1.07	0.00
Meningeal Cells, donor1	11493-119E8	58.93	1.49	0.37	0.25	0.12	0.25
Meningeal Cells, donor2	11573-120E7	51.50	2.20	0.00	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	60.80	1.71	0.41	0.33	0.57	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	40.78	0.00	0.00	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	31.90	1.31	0.30	0.10	0.40	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	19.71	2.63	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	28.78	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	61.71	6.46	0.72	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	43.84	5.93	0.64	0.21	1.27	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	64.84	12.06	0.50	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	25.71	0.66	0.44	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	32.88	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	29.87	0.41	0.00	0.41	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.19	1.52	0.00	0.14	0.00	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	22.30	0.00	0.00	0.74	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	53.29	2.89	0.00	0.66	0.53	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.54	0.30	0.30	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	26.26	1.28	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	82.59	7.09	0.00	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.53	1.25	0.31	0.00	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	27.58	0.00	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	40.04	2.65	0.00	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	30.03	3.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	32.37	2.38	0.22	0.14	0.14	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	47.26	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.17	2.22	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	32.39	4.42	0.59	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	28.52	2.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.46	2.28	0.41	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.28	2.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	46.08	2.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	26.62	1.63	0.20	0.00	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.84	4.36	1.19	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	0.88	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	29.26	3.04	1.14	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	29.92	2.12	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	36.83	5.52	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	35.77	4.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	35.21	13.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.13	4.01	0.25	0.50	1.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.50	7.13	0.95	0.71	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	43.68	8.29	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	43.06	7.60	0.69	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	52.16	10.10	1.05	0.00	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	50.96	13.05	0.20	0.20	0.61	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	35.40	8.15	0.00	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	57.13	12.89	1.33	0.00	0.67	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	45.12	10.29	0.22	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	63.37	18.25	0.51	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	62.97	19.88	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	51.91	15.22	0.54	0.27	1.09	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	73.23	20.00	0.29	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	49.06	9.81	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	42.77	9.13	0.00	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	70.44	21.61	1.20	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	41.14	13.71	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	40.05	9.01	1.00	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	32.62	20.39	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	48.61	13.14	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	68.43	20.97	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	42.27	13.45	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	39.42	9.67	0.74	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	70.29	17.40	0.00	0.00	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	48.62	11.05	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	36.58	4.44	0.00	0.00	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	73.96	13.13	0.44	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	46.87	7.46	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	42.92	8.14	0.56	0.84	0.56	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	66.92	14.96	0.83	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	41.96	9.91	0.00	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	45.25	9.05	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	65.53	12.94	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	46.18	6.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	85.94	19.35	1.14	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	57.21	7.05	0.28	0.14	0.69	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	41.20	8.29	0.00	0.26	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	73.78	12.87	0.43	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	43.83	6.35	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	53.38	7.74	0.00	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	72.44	11.67	0.30	0.90	1.50	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	42.80	5.23	0.28	0.14	0.28	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	41.41	4.46	0.32	0.32	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	73.64	12.83	0.22	0.44	1.33	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	56.12	9.86	0.76	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	48.87	7.39	0.85	0.00	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	65.63	8.11	0.98	0.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	51.48	4.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	57.34	6.76	0.29	0.29	0.88	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	72.08	8.65	0.86	0.86	1.15	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	67.18	4.12	0.00	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	56.88	4.47	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.66	0.33	0.00	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	33.21	0.99	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.01	0.93	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.16	0.38	1.13	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.30	2.13	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.72	0.34	0.34	0.11	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	19.89	2.21	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.08	0.73	0.00	0.73	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	29.56	4.67	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	33.67	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	21.21	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	34.57	1.69	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	44.94	8.17	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	35.60	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	28.70	6.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	142.75	17.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	68.51	22.84	3.26	0.00	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	14.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	175.69	37.65	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	66.79	4.74	0.00	1.08	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	68.46	4.70	2.61	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	32.71	3.34	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	35.89	4.59	1.25	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	42.97	2.85	1.14	0.19	0.76	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	82.98	11.17	0.00	0.00	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	25.84	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	158.04	18.38	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	42.69	2.51	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	45.79	6.04	0.46	0.23	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	45.67	3.78	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	68.33	8.20	0.42	0.00	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	311.77	22.27	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.67	5.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	37.62	3.52	0.27	0.00	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	48.06	9.97	0.91	0.00	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	39.68	6.70	0.82	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	73.08	12.58	0.91	0.91	1.28	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	43.50	4.77	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	42.02	8.40	1.20	0.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	41.35	5.58	0.00	0.66	0.98	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	49.76	10.57	0.98	0.16	0.33	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	71.61	9.88	0.71	0.35	0.88	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	42.90	6.33	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	48.73	10.57	2.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	44.35	4.50	0.00	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	57.94	14.49	0.69	1.38	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	164.35	20.23	2.53	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	68.17	10.25	0.22	0.00	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	42.76	4.66	0.00	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	41.77	8.07	0.71	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.78	5.15	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	27.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	35.99	3.33	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.50	9.02	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	37.70	3.57	0.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	41.79	7.43	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.00	2.65	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	37.80	4.89	0.33	0.65	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	25.28	0.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	59.70	5.88	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	4.41	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	33.24	7.98	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	48.12	3.47	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	36.37	3.06	0.77	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.36	1.81	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	46.19	3.98	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	52.18	6.10	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	255.48	10.22	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	45.73	0.61	0.00	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	33.99	1.89	0.00	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	33.29	1.82	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	43.51	4.75	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	52.15	7.94	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	202.32	5.06	0.00	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	48.57	5.84	0.25	0.62	0.50	0.12
Myoblast, donor2	11322-117D8	45.26	3.45	0.58	0.96	0.19	0.38
Myoblast, donor3	11398-118D3	56.67	5.21	0.34	0.50	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	58.23	0.88	0.00	0.44	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	73.19	4.92	0.92	0.62	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	73.88	2.41	2.41	0.60	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	83.56	5.89	0.55	1.10	0.18	0.18
Neural stem cells, donor1	11275-116H6	93.28	3.63	0.36	0.36	1.09	0.00
Neural stem cells, donor2	11352-117H2	88.58	1.93	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	71.69	7.97	2.28	2.28	1.14	0.00
Neurons, donor2	11574-120E8	40.73	0.88	0.66	0.22	0.22	0.00
Neurons, donor3	11655-122E8	69.06	7.40	1.64	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	96.51	2.78	0.93	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	81.17	8.70	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	169.81	6.72	2.44	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	36.45	0.36	0.24	0.36	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	33.21	0.33	0.33	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	27.68	1.20	0.40	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	63.46	9.50	0.55	0.28	0.55	0.28
Olfactory epithelial cells, donor2	11934-125I8	71.79	12.30	0.58	2.89	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	72.87	10.90	0.91	0.91	0.91	0.45
Olfactory epithelial cells, donor4	11936-126A1	86.49	10.03	0.29	0.29	0.58	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	42.73	2.41	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	33.61	2.77	1.06	0.00	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	24.01	1.14	0.00	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	49.66	4.34	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	19.15	0.98	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	44.25	2.11	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	55.81	4.80	0.71	0.36	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	117.17	17.77	2.27	1.18	2.02	0.59
Pericytes, donor1	11491-119E6	13.57	0.22	0.11	0.11	0.11	0.00
Pericytes, donor2	11571-120E5	15.17	0.00	0.23	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	28.69	2.03	0.61	0.61	0.00	0.00
Perineurial Cells, donor1	11499-119F5	47.81	1.58	0.45	0.11	0.11	0.00
Perineurial Cells, donor2	11579-120F4	31.84	1.47	0.09	0.09	0.37	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	114.11	6.06	2.55	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	76.40	6.61	1.71	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	86.84	9.45	1.55	0.26	0.52	0.00
Placental Epithelial Cells, donor1	11278-116H9	29.18	1.67	0.96	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	22.18	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.83	0.79	0.39	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	51.90	6.65	0.00	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	47.08	4.31	1.13	0.38	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	59.52	5.22	1.44	0.00	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	49.53	4.73	0.45	0.45	0.45	0.68
Preadipocyte - omental, donor1	11468-119C1	58.93	5.54	1.92	0.53	0.32	0.75
Preadipocyte - omental, donor2	11329-117E6	60.67	3.93	0.44	0.00	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	52.86	4.87	0.43	0.57	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	41.34	2.95	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	20.27	3.07	0.31	0.00	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	101.64	12.93	0.35	1.42	0.53	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	50.57	5.11	0.51	0.34	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	97.34	8.76	0.65	0.47	0.65	0.47
Preadipocyte - visceral, donor2	11357-117H7	83.75	4.60	0.46	1.84	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	69.80	7.63	0.10	0.63	0.31	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	36.20	3.62	0.75	0.45	0.30	0.15
Prostate Epithelial Cells, donor2	11331-117E8	46.04	6.91	0.54	0.41	0.14	0.54
Prostate Epithelial Cells, donor3	11404-118D9	85.55	6.25	1.78	1.96	0.00	0.37
Prostate Stromal Cells, donor1	11254-116F3	52.96	4.33	0.23	0.23	0.23	0.00
Prostate Stromal Cells, donor2	11332-117E9	66.88	6.45	0.36	2.15	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	43.38	3.13	1.04	0.52	0.21	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.55	1.09	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	38.33	0.76	0.00	0.21	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	23.84	0.51	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	22.05	1.42	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	38.53	0.32	0.00	0.21	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	24.51	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	33.42	4.04	0.13	0.00	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	42.63	2.89	0.00	0.89	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	27.95	2.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	20.91	0.44	0.00	0.00	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	33.86	1.88	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	10.82	0.00	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	53.42	3.49	0.27	0.27	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.19	2.11	0.00	0.42	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	25.65	1.35	0.00	0.19	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	47.19	3.63	0.26	0.00	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	21.89	0.57	0.28	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.11	1.00	0.00	0.00	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	94.75	7.35	0.53	0.13	1.74	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	49.14	4.47	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	34.12	1.65	0.55	0.55	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	62.65	5.22	1.74	0.00	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	68.65	5.72	0.26	0.39	0.52	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.82	3.48	0.30	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	59.90	3.57	0.45	0.00	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	73.93	3.23	0.62	0.99	1.36	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	49.76	4.08	0.00	0.70	0.23	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	65.87	4.16	0.46	0.46	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.50	3.56	0.00	0.00	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	54.31	3.93	0.00	1.06	0.61	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	56.09	2.33	0.18	0.00	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	52.36	4.45	0.00	0.57	0.14	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	49.36	3.33	0.11	0.54	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.10	2.88	0.22	0.22	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	56.40	3.63	0.38	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	51.89	3.73	0.00	0.37	0.37	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	73.66	5.45	0.38	0.19	0.56	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	63.17	4.78	0.27	0.00	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	58.40	3.60	0.10	0.58	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	60.92	4.01	0.19	0.57	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	56.39	4.16	0.64	0.21	0.53	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	48.21	3.08	0.28	1.12	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	56.57	4.79	0.51	0.85	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	56.89	5.11	0.18	0.18	0.73	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	51.02	4.91	0.25	0.37	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	57.89	5.24	0.27	0.67	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	53.54	4.95	0.24	0.47	0.47	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	46.43	3.77	0.20	0.40	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	51.68	6.55	0.94	0.23	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	51.01	5.81	0.00	0.21	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	63.27	4.87	0.22	2.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	54.10	7.52	0.21	0.00	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	59.89	5.79	0.40	0.13	1.21	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	59.94	4.26	0.34	0.51	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	59.00	6.75	0.58	0.58	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	58.29	5.33	0.69	0.34	0.86	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	59.53	5.21	0.14	0.27	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	54.67	4.10	0.33	0.99	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	58.63	3.24	0.34	0.00	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	59.92	3.40	0.00	1.04	0.44	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	64.24	4.00	0.27	0.27	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	61.53	6.36	0.55	0.00	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	58.57	2.86	0.24	0.71	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	78.40	5.24	0.60	0.40	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	50.10	3.39	0.57	0.19	0.57	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	53.10	6.29	0.35	0.70	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	52.28	3.63	0.91	0.00	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	38.92	2.45	0.37	0.12	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	116.59	8.44	1.75	0.29	1.02	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	54.15	0.00	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	37.07	2.11	0.00	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	43.65	3.85	0.68	0.45	0.45	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	65.60	4.49	0.60	0.90	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	43.81	3.42	0.47	0.24	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	51.87	3.20	1.28	0.43	0.00	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	64.91	4.81	1.80	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	22.94	0.75	0.00	0.00	0.00	0.19
Schwann Cells, donor2	11578-120F3	30.62	3.40	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	32.42	2.41	0.66	0.66	0.00	0.00
Sebocyte, donor1	11220-116B5	71.21	6.57	0.00	0.00	0.55	0.55
Sebocyte, donor2	11301-117B5	51.93	8.27	0.00	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	34.63	3.09	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	89.46	16.57	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	56.49	5.65	0.00	5.65	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	47.33	1.32	0.35	0.18	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	33.25	2.89	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	33.44	3.34	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	36.92	1.26	0.00	0.16	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	36.72	0.74	0.15	0.45	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	74.18	2.77	0.31	0.46	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	60.23	2.02	0.76	0.50	0.38	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	47.23	1.71	0.29	0.86	0.43	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	66.97	3.67	0.50	0.50	0.40	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	33.36	1.18	0.59	0.08	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	55.73	3.62	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	20.09	3.30	0.28	0.00	0.00	0.28
Skin - palm, donor1	10286-104F7	188.03	24.17	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	24.22	3.60	0.14	0.29	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	154.58	20.45	7.36	0.00	2.45	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	32.33	3.51	0.26	0.00	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	87.99	7.09	0.83	0.28	0.56	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	83.27	7.60	0.28	0.56	0.28	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	197.28	18.40	7.82	0.42	0.63	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	93.69	6.82	0.90	0.60	0.15	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	51.53	4.32	0.00	0.93	0.31	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	46.47	4.22	0.89	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	42.91	4.11	0.59	0.59	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	37.13	3.09	0.66	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	27.17	1.58	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	40.17	9.27	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	50.04	5.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.74	1.06	0.00	0.13	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.11	2.88	0.22	0.66	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	51.72	8.32	0.64	0.26	0.13	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	33.21	1.95	0.33	0.00	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	41.94	2.36	0.89	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	42.42	2.85	0.00	0.14	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	18.22	0.65	0.49	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	50.54	4.26	0.61	0.61	0.61	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.28	1.52	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	34.33	2.86	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.11	0.88	0.59	0.29	0.59	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	33.58	0.86	0.22	0.65	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.95	0.73	0.31	0.42	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.48	2.17	0.15	0.15	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	26.95	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.40	2.09	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.73	1.02	0.00	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	40.29	1.96	0.24	0.39	0.63	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	45.49	3.22	0.50	0.20	0.20	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	70.09	11.61	0.00	0.23	0.46	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	32.00	7.85	0.00	0.00	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.54	2.65	0.79	0.00	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	53.40	3.86	0.27	0.13	0.67	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.19	2.50	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	36.02	3.55	0.76	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	57.29	4.82	0.90	0.15	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	30.01	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	93.04	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	37.21	2.79	0.93	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	48.97	5.05	0.50	0.50	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	33.53	7.21	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	14.75	1.18	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	61.81	4.25	0.42	0.00	0.42	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	3.27	0.47	0.00	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.15	1.30	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	29.06	1.53	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.02	3.38	0.00	0.00	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	43.46	2.38	0.28	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	37.03	2.09	0.08	0.08	0.50	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.67	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.33	0.98	0.00	0.00	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	47.72	5.52	1.10	0.22	0.44	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	42.72	2.93	0.59	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	47.42	3.11	0.78	0.19	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	62.94	11.37	0.26	0.53	0.26	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	41.66	8.18	0.74	1.86	1.86	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	79.05	16.17	1.44	2.16	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	42.02	9.08	0.57	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	59.08	9.85	0.39	0.39	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	61.71	7.11	1.02	1.02	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	60.30	3.59	0.40	1.20	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	51.00	5.43	1.25	1.67	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	60.50	5.50	2.29	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	58.41	5.39	0.34	0.17	0.34	0.00
Synoviocyte, donor2	11368-117I9	40.73	3.69	0.34	0.34	0.00	0.17
Synoviocyte, donor3	11440-118H9	38.43	0.89	0.00	0.67	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	42.88	1.79	0.36	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	32.19	0.93	0.00	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	46.81	1.72	0.50	0.00	0.07	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	21.26	3.09	0.39	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	40.66	4.58	0.57	0.00	0.57	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	100.02	6.89	0.98	0.25	1.72	0.62
Urethra, donor2	10319-105A4	118.70	17.98	1.80	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	28.43	1.06	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	21.23	1.20	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	19.94	3.21	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	52.38	1.56	0.22	0.22	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	87.20	2.67	1.78	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	110.08	7.15	2.86	0.00	1.43	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	78.72	2.05	1.37	0.00	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	65.08	3.10	1.03	0.00	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	67.40	3.49	0.58	0.00	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	76.01	4.16	1.04	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	89.03	3.67	0.92	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	61.16	2.74	1.83	3.65	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	63.53	8.76	0.25	0.12	0.74	0.37
Wilms' tumor cell line:HFWT	10597-108E3	81.84	5.28	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	69.83	8.10	1.40	0.56	0.00	0.28
achilles tendon, donor2	10292-104G4	82.66	12.40	0.00	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.60	1.53	0.00	0.76	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	68.96	0.93	0.70	0.46	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	40.84	0.59	0.36	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	70.21	2.45	1.09	0.82	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	128.74	12.93	0.00	2.53	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	125.83	11.00	1.27	0.63	1.06	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	69.14	10.89	0.82	0.27	1.09	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.93	2.64	0.44	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	48.59	1.23	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	51.26	2.33	0.78	0.39	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.50	1.29	0.18	0.00	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	86.91	8.37	1.86	1.16	0.93	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	31.07	1.04	1.04	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	34.19	1.46	0.88	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	31.14	0.93	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	25.09	0.82	0.82	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	20.87	0.61	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.15	1.28	1.28	0.00	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	29.42	0.61	0.61	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	30.81	0.96	0.24	0.00	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	29.18	0.45	0.22	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	54.37	6.67	0.33	0.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	98.48	0.00	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	95.67	10.17	1.88	0.75	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	222.43	43.18	3.05	0.87	2.62	3.05
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	41.24	3.75	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	87.37	4.71	0.71	0.24	0.00	0.94
adipose tissue, adult, pool1	10010-101C1	51.65	1.40	0.93	0.31	0.31	0.16
adipose, donor1	10184-103D4	96.17	9.38	1.17	2.93	0.00	1.17
adipose, donor2	10185-103D5	52.72	0.41	2.84	0.00	0.00	0.00
adipose, donor3	10186-103D6	50.37	1.36	0.27	0.54	0.00	0.54
adipose, donor4	10187-103D7	42.47	1.73	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	33.46	0.95	0.47	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	54.57	0.00	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	131.94	3.60	1.47	0.67	0.53	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	34.66	1.79	1.43	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	49.38	3.01	2.55	0.23	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	26.37	1.01	2.37	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	34.76	0.29	1.77	0.00	0.00	0.29
amygdala - adult, donor10196	10167-103B5	54.55	2.37	8.30	1.19	3.56	0.00
amygdala, adult, donor10252	10151-102I7	71.98	2.43	10.75	1.42	1.22	0.00
amygdala, newborn, donor10223	10360-105E9	36.15	3.87	5.49	0.00	2.26	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	89.77	3.82	1.27	0.38	0.89	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	67.29	2.21	0.22	1.32	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	65.81	2.34	0.67	0.33	1.00	0.67
aorta, adult, pool1	10052-101G7	104.54	5.49	1.77	1.37	0.39	0.20
appendix, adult	10189-103D9	76.85	6.21	1.94	1.55	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.09	0.69	0.69	0.69	0.69	0.34
artery, adult	10190-103E1	92.39	4.08	0.00	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	69.39	1.01	0.29	0.29	0.14	0.43
b cell line:RPMI1788	10427-106D4	26.17	0.89	0.15	0.15	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	120.69	15.81	0.83	1.39	0.28	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	57.65	4.07	0.30	0.00	0.00	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	70.97	3.68	0.17	0.50	0.17	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	36.91	1.68	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	81.70	1.09	0.43	0.22	0.43	0.00
blood, adult, pool1	10053-101G8	55.37	0.00	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	87.35	12.85	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	76.26	11.47	0.67	4.05	2.70	0.00
brain, adult, donor1	10084-102B3	46.13	3.08	2.05	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	54.12	1.45	3.45	0.67	0.33	0.22
brain, fetal, pool1	10085-102B4	69.46	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	44.27	3.63	0.00	1.65	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	54.17	0.75	1.00	0.00	0.25	0.25
breast, adult, donor1	10080-102A8	61.87	0.63	0.00	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	38.11	1.27	0.64	0.13	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	58.44	2.78	0.00	0.31	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.74	1.15	0.46	1.38	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	21.06	0.97	0.24	0.00	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	22.10	0.94	3.29	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	35.11	2.84	0.55	0.33	0.11	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	37.39	0.63	1.27	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	61.49	1.60	0.27	1.60	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	89.80	3.45	3.45	1.15	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	73.29	1.51	4.52	1.00	0.17	0.50
caudate nucleus, adult, donor10258	10379-105H1	77.18	1.53	0.00	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	56.40	4.03	2.20	0.00	2.56	0.37
cerebellum - adult, donor10196	10173-103C2	125.27	2.91	5.83	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	130.67	1.71	1.28	1.71	0.00	0.64
cerebellum, adult, pool1	10083-102B2	84.86	1.72	3.10	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	85.52	3.32	0.83	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	55.47	3.78	1.76	0.00	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	69.43	10.96	1.46	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	47.30	1.44	0.72	0.29	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	95.12	14.42	0.50	0.50	0.50	0.83
cervix, adult, pool1	10013-101C4	112.65	7.87	1.68	0.63	1.26	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	60.33	3.34	0.00	0.14	0.28	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	50.94	10.45	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	55.80	1.24	0.00	0.00	0.00	0.12
choriocarcinoma cell line:SCH	10785-110H2	44.85	0.86	0.00	0.37	0.12	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	38.19	0.24	0.00	0.24	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	29.06	0.85	0.57	0.28	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	59.56	5.77	0.20	0.20	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	32.97	1.10	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	29.28	4.04	2.02	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	96.63	12.68	0.96	0.19	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	48.78	2.96	1.48	0.00	0.63	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	74.73	1.03	0.51	1.03	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	70.87	1.45	0.48	0.24	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	80.22	0.20	0.00	0.81	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	84.51	0.59	0.29	0.29	0.00	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	84.96	2.61	1.82	0.00	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.34	1.14	0.23	0.91	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	28.11	1.04	0.00	0.17	0.00	0.69
colon carcinoma cell line:CACO-2	10513-107D9	51.25	3.84	0.55	0.18	0.00	0.37
colon carcinoma cell line:COLO-320	10420-106C6	55.49	1.14	0.38	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	85.68	15.47	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	133.48	16.92	1.29	0.47	0.24	0.82
colon, fetal, donor1	10070-101I7	132.25	12.36	3.09	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	279.59	32.08	4.58	0.00	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	25.04	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	149.15	10.20	0.42	0.00	0.42	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	79.24	5.89	0.30	0.00	0.45	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	87.71	9.17	0.14	0.00	0.56	0.14
corpus callosum, adult, pool1	10042-101F6	132.23	2.87	4.20	0.55	1.33	0.11
cruciate ligament, donor2	10295-104G7	91.58	10.54	1.62	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	108.35	9.63	1.61	0.00	0.80	0.00
diencephalon, adult	10193-103E4	56.64	3.60	1.92	0.48	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	24.11	0.00	0.23	0.69	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	178.23	10.26	1.54	0.26	1.03	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.92	1.44	0.00	0.00	0.24	0.24
ductus deferens, adult	10196-103E7	69.77	3.49	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	76.33	4.32	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	69.15	6.62	0.74	1.47	1.47	0.00
dura mater, adult, donor1	10041-101F5	133.13	5.45	3.06	0.50	0.66	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	49.74	11.33	0.22	0.00	1.33	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	29.95	0.86	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	61.66	1.85	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	51.46	0.61	0.30	1.21	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.66	2.47	0.00	0.31	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	53.85	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	74.75	2.68	0.00	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	73.22	3.62	0.36	0.54	0.00	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	67.86	7.88	0.16	0.96	0.16	1.29
epidermoid carcinoma cell line:A431	10426-106D3	43.91	4.00	0.33	0.00	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	62.80	4.18	0.66	0.22	0.33	0.11
epididymis, adult	10197-103E8	74.51	4.81	0.84	0.63	0.42	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	193.38	22.71	3.02	1.24	1.95	1.95
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	33.03	0.00	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	58.45	4.59	0.13	1.44	0.13	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	65.94	3.84	0.20	0.98	0.49	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	59.82	5.60	0.00	0.67	0.22	0.67
esophagus, adult, pool1	10015-101C6	95.03	9.77	1.06	0.32	0.21	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	56.48	0.25	0.25	0.13	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	55.54	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	82.06	12.63	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	62.51	4.46	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	67.64	3.44	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	68.50	7.29	0.00	0.00	0.00	2.91
eye, fetal, donor1	10054-101G9	43.73	1.53	1.27	0.25	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	45.65	1.41	0.26	0.13	0.00	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	78.35	4.99	0.47	0.24	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	82.47	1.78	4.13	0.38	0.66	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	33.93	1.20	0.30	0.60	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	43.89	1.19	0.09	0.09	0.46	0.00
gall bladder, adult	10198-103E9	77.98	5.79	1.69	0.72	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	48.32	1.61	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	49.30	1.49	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	36.96	1.69	0.63	1.27	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	48.74	0.97	0.19	0.77	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	61.32	1.48	0.49	0.00	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	60.40	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	93.21	8.45	1.14	2.28	0.91	0.00
giant cell carcinoma cell line:LU65	10487-107B1	22.14	0.11	0.00	0.11	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	46.05	1.26	0.00	0.00	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	83.56	7.23	0.00	0.50	0.00	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	77.48	8.34	0.42	0.95	0.42	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	80.47	7.02	0.98	0.00	0.28	0.28
glioblastoma cell line:T98G	10485-107A8	40.62	1.77	0.22	0.00	0.77	0.22
glioma cell line:GI-1	10413-106B8	30.17	1.17	0.59	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	98.40	3.64	4.37	0.00	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	126.20	2.69	3.17	1.22	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	52.03	5.48	1.37	4.11	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	62.88	7.99	1.07	0.00	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	188.43	12.24	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	51.52	6.08	0.32	0.32	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	37.19	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	32.47	1.83	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	39.29	1.93	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	34.49	1.44	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	32.92	2.06	0.00	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	50.76	1.10	2.21	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	53.16	2.30	0.29	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	136.63	11.36	4.19	0.60	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	138.06	11.24	1.57	0.26	2.61	0.00
heart - tricuspid valve, adult	10207-103F9	84.93	4.16	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	91.01	14.08	0.41	0.82	1.22	0.41
heart, adult, diseased, donor1	10051-101G6	136.69	16.61	0.43	2.55	2.13	0.43
heart, adult, pool1	10016-101C7	158.45	11.50	0.00	0.00	0.69	1.38
heart, fetal, pool1	10046-101G1	221.07	13.25	2.98	0.41	3.70	1.75
hepatic mesenchymal tumor cell line:LI90	10778-110G4	67.88	3.70	0.31	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	47.57	5.95	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	53.70	4.20	0.00	0.55	0.11	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	54.98	3.76	0.36	0.36	0.24	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	63.36	4.55	0.20	0.51	0.30	0.00
hepatoma cell line:Li-7	10484-107A7	52.72	0.67	0.22	0.33	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	46.53	2.81	0.30	0.50	0.00	0.20
hippocampus - adult, donor10196	10169-103B7	57.73	1.89	5.68	0.00	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	82.46	1.63	5.31	0.41	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	42.82	1.99	4.98	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	38.42	3.88	2.82	0.00	1.41	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	53.71	1.22	0.61	1.83	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	32.40	1.37	0.00	0.79	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	42.65	1.02	0.00	0.51	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	40.60	1.13	0.00	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	38.99	0.52	0.00	0.26	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.62	0.38	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	57.22	1.46	0.58	0.29	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	46.96	1.94	0.43	0.22	0.22	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	56.72	2.50	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	40.02	2.60	0.71	0.00	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	46.13	1.29	0.16	0.32	0.32	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	48.48	3.37	0.00	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.48	0.63	0.16	0.63	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	26.53	0.98	0.49	1.47	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	52.37	1.75	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	55.94	1.15	0.19	0.00	0.76	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.43	2.62	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	60.97	4.50	0.50	1.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	60.66	1.70	0.38	0.57	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	56.38	1.36	1.36	0.45	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	57.64	2.82	0.63	0.31	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	50.46	3.59	0.82	0.33	0.33	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	48.48	2.03	0.58	0.29	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.92	3.29	0.00	0.90	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	34.55	1.48	0.18	0.37	0.37	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	32.52	0.57	0.29	0.57	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	55.53	3.27	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	55.28	4.93	0.35	2.11	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	50.68	2.53	0.00	0.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	52.96	4.24	0.00	0.61	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	49.13	3.62	1.03	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	61.10	2.66	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	45.15	2.31	0.00	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	36.30	3.07	0.00	0.51	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	49.98	6.06	1.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	38.31	5.04	0.34	0.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	34.54	0.72	0.00	0.00	0.48	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	31.64	1.34	0.45	0.00	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	35.12	0.98	0.00	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	47.37	1.83	0.00	1.22	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	172.42	0.00	0.00	13.01	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	51.96	1.65	0.33	0.33	0.33	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.97	1.64	0.55	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	43.79	2.90	0.36	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	40.21	2.49	0.36	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	48.93	4.77	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	51.06	1.49	0.00	0.14	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.29	1.08	0.27	0.27	0.00	0.27
immature langerhans cells, donor1	11904-125F5	212.36	50.61	7.02	1.70	4.60	2.42
immature langerhans cells, donor2	11905-125F6	205.95	46.74	28.52	0.79	1.58	2.38
insula, adult, pool1	10039-101F3	80.63	2.46	7.48	0.38	0.76	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	14.63	0.33	0.00	0.00	0.33	0.65
kidney, adult, pool1	10017-101C8	69.69	6.21	0.80	0.20	0.50	0.20
kidney, fetal, pool1	10045-101F9	53.19	2.05	0.64	0.07	0.28	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	36.64	1.14	0.43	0.00	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.22	0.00	0.00	0.28	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	94.14	8.07	0.73	0.55	0.37	0.73
left atrium, adult, donor1	10079-102A7	96.44	15.26	0.00	1.09	0.54	0.00
left ventricle, adult, donor1	10078-102A6	114.78	16.69	0.51	1.52	0.51	1.01
leiomyoblastoma cell line:G-402	10721-110A1	36.39	3.28	1.09	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	35.57	6.83	0.36	0.72	0.00	0.72
leiomyoma cell line:15242A	10570-108B3	36.96	8.15	0.00	1.09	1.09	0.00
leiomyoma cell line:15425	10571-108B4	40.06	4.61	0.73	1.46	0.49	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	2.09	0.00	0.00	0.00	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	33.17	0.47	0.59	0.12	0.12	0.35
liposarcoma cell line:KMLS-1	10782-110G8	41.40	1.25	0.16	0.16	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	46.54	3.17	0.12	0.24	0.12	0.00
liver, adult, pool1	10018-101C9	73.74	7.13	0.49	0.16	0.49	0.49
liver, fetal, pool1	10086-102B5	73.38	8.47	0.94	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	112.72	4.96	1.02	0.15	0.73	0.73
locus coeruleus, adult, donor10252	10165-103B3	74.74	2.95	2.03	0.37	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	48.53	2.82	0.85	0.28	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	65.62	10.09	2.52	0.42	2.10	0.42
lung adenocarcinoma cell line:A549	10499-107C4	60.76	1.52	0.14	0.42	0.42	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	42.74	3.45	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	43.24	1.85	0.79	0.13	0.00	0.00
lung, adult, pool1	10019-101D1	76.78	0.83	0.71	0.12	0.24	0.24
lung, fetal, donor1	10068-101I5	167.53	7.71	3.42	0.00	5.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	80.19	3.67	1.83	0.92	0.00	0.46
lymph node, adult, donor1	10077-102A5	54.44	1.89	0.47	0.95	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	33.53	0.88	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	21.43	1.36	0.00	0.00	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	147.81	21.24	3.40	1.70	2.55	6.80
mature adipocyte, donor1	12231-129F8	65.71	4.00	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	64.75	2.08	0.42	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	65.43	2.13	0.24	0.00	0.00	0.47
mature adipocyte, donor4	12234-129G2	79.23	1.58	0.00	0.26	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	62.66	0.71	0.00	0.00	0.24	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	78.96	3.38	6.77	0.00	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	93.98	2.57	4.60	1.66	1.29	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	56.87	3.49	1.91	0.64	0.00	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	50.75	4.26	5.54	0.85	5.97	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	92.98	3.71	6.08	7.43	0.68	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	95.71	3.18	5.31	0.42	0.00	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	55.86	0.00	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	301.43	0.00	14.35	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	31.94	5.03	5.38	0.00	1.44	0.72
medulla oblongata - adult, donor10196	10174-103C3	102.54	6.49	1.30	0.00	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	90.25	2.48	1.24	1.39	0.93	0.15
medulla oblongata, adult, pool1	10038-101F2	85.46	3.27	1.63	0.16	0.82	0.24
medulla oblongata, newborn, donor10223	10361-105F1	70.13	4.17	1.04	0.35	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	61.33	0.44	0.44	0.66	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	51.84	1.10	0.61	0.24	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	52.90	2.59	0.29	0.14	0.00	0.00
melanoma cell line:G-361	10465-106H6	32.58	1.36	0.27	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	59.70	1.27	0.18	1.63	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	66.09	0.88	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	51.59	2.59	0.26	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	47.87	4.14	0.31	0.46	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	53.63	5.27	0.91	0.00	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	44.31	4.56	0.83	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	48.04	4.64	0.00	0.28	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.59	2.89	0.19	0.39	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	49.97	5.55	0.00	0.69	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.75	5.66	0.34	0.00	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.50	4.03	0.23	0.23	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	35.02	1.86	0.66	0.27	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	46.18	3.78	0.14	0.41	0.27	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	55.48	6.40	0.14	0.71	0.57	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.80	3.95	0.66	0.66	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	36.67	2.49	0.28	0.55	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	50.27	3.84	0.00	0.35	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	40.83	3.27	0.61	0.61	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	44.93	2.88	0.36	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	27.10	0.72	0.10	0.41	0.00	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	32.37	4.79	0.91	0.68	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.87	5.87	0.00	0.42	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	49.46	5.68	0.45	0.60	0.15	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	36.15	2.10	0.18	0.26	0.53	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	66.64	7.36	1.47	0.74	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	42.64	5.15	1.43	0.00	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	87.15	11.79	1.26	3.79	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	50.23	4.57	0.91	0.46	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	42.72	3.84	1.02	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	54.97	4.19	0.79	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	47.45	4.62	1.23	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.48	3.53	0.71	0.94	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	51.45	6.77	1.35	0.34	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	52.27	3.14	0.00	1.57	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	36.14	6.49	0.93	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	58.26	5.77	1.15	0.87	0.00	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	49.31	3.79	0.67	0.22	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	47.83	4.09	0.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	71.13	5.87	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	38.94	3.02	1.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	49.53	2.46	1.23	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	45.96	5.58	0.43	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	54.89	4.22	0.32	1.30	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	49.47	1.45	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	48.51	7.46	0.00	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	53.16	3.27	0.00	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	46.65	3.89	0.39	0.00	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	41.97	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	51.66	2.98	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	37.95	4.74	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	41.43	4.87	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	49.40	5.07	0.00	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	39.66	1.72	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	29.75	1.22	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.93	1.59	0.79	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	30.66	1.18	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.42	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	26.02	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	28.22	2.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	26.72	0.99	0.00	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	21.31	2.24	0.00	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.26	2.54	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.97	1.21	0.00	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	2.18	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	3.80	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	43.09	3.64	0.00	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	0.00	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	43.66	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	31.55	1.59	0.20	0.20	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.20	0.65	0.65	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	37.69	3.06	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	167.90	28.63	2.32	0.00	5.42	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	72.76	2.13	0.24	0.24	0.71	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	80.62	2.78	0.93	0.00	1.16	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	12.82	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	48.19	7.71	0.51	0.41	0.51	0.21
mesothelioma cell line:Mero-25	10850-111F4	26.33	1.82	0.00	0.23	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	37.16	2.20	0.00	0.73	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	39.86	3.99	0.22	0.44	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	54.14	5.78	0.26	0.26	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	71.32	9.70	0.17	1.19	0.85	0.17
mesothelioma cell line:Mero-84	10855-111F9	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	21.74	1.24	0.00	0.21	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	50.85	8.61	0.66	0.17	0.17	0.33
mesothelioma cell line:NCI-H226	10846-111E9	48.87	5.43	0.00	0.36	0.54	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	35.53	3.07	0.17	0.00	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	67.18	7.89	0.25	0.25	0.25	0.76
mesothelioma cell line:No36	10857-111G2	46.32	1.63	0.98	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	35.49	2.98	0.00	0.00	0.00	0.54
migratory langerhans cells, donor1	11901-125F2	102.10	5.37	1.15	0.38	1.73	0.96
migratory langerhans cells, donor2	11902-125F3	84.99	5.13	1.34	0.24	0.73	0.12
migratory langerhans cells, donor3	11903-125F4	86.33	3.05	0.72	0.00	1.08	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	61.70	1.31	0.00	1.63	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	63.37	3.39	0.42	1.06	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	79.24	2.76	0.23	0.46	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	63.18	6.09	0.38	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	37.51	0.74	0.18	0.18	0.00	0.18
myeloma cell line:PCM6	10474-106I6	50.60	0.59	0.00	0.20	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	63.92	7.61	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	68.45	7.06	0.59	0.00	0.20	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	100.62	6.13	1.67	0.33	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	93.69	6.99	2.06	0.29	0.00	0.74
nasal epithelial cells, donor2	12227-129F4	92.73	9.94	1.10	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	96.40	1.15	0.69	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	66.60	0.56	0.00	0.00	0.94	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	26.36	0.84	0.00	1.05	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	60.75	0.56	0.37	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	48.16	0.24	2.85	0.71	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	26.77	0.32	0.63	0.00	0.00	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	21.13	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	14.62	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	65.48	4.79	0.53	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	208.25	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	185.93	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	132.59	18.94	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	63.59	0.34	1.18	0.51	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	35.22	2.40	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	87.85	10.58	0.96	0.64	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	68.58	7.88	1.05	1.05	1.84	0.00
nucleus accumbens, adult, pool1	10037-101F1	88.49	2.34	2.91	0.47	0.47	0.28
occipital cortex - adult, donor10196	10172-103C1	113.32	8.24	4.12	0.00	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	108.96	4.56	1.07	1.07	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	35.30	5.46	5.10	0.00	2.18	0.36
occipital lobe, adult, donor1	10076-102A4	84.75	3.15	2.89	1.57	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	127.44	0.86	6.87	0.43	0.00	0.43
occipital pole, adult, pool1	10036-101E9	46.99	1.26	1.81	0.08	0.00	0.00
olfactory region, adult	10195-103E6	68.01	1.15	6.11	0.38	0.96	0.38
optic nerve, donor1	10277-104E7	196.10	6.00	8.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	47.61	4.21	0.46	0.11	0.57	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	49.46	0.96	1.10	0.14	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.29	1.02	0.85	0.34	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	44.01	1.39	0.12	0.58	0.35	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	90.54	8.23	0.59	0.00	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	128.00	7.47	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	54.29	1.91	0.21	0.42	1.06	0.00
ovary, adult, pool1	10020-101D2	66.39	0.96	1.14	0.09	0.17	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	51.88	3.67	0.00	0.00	0.55	0.37
pancreas, adult, donor1	10049-101G4	57.38	0.00	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	44.45	0.56	0.28	0.28	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	51.79	3.24	0.34	1.87	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	39.24	1.49	0.83	0.17	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	78.34	1.19	4.39	0.37	0.37	0.00
parietal cortex, adult, donor10258	10373-105G4	55.78	0.73	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	83.70	2.82	4.70	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	78.67	1.43	3.14	1.71	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	76.22	1.67	3.88	0.26	0.44	0.26
parietal lobe, fetal, donor1	10072-101I9	132.87	3.88	5.82	1.94	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	41.12	4.49	5.98	1.50	3.36	0.75
parotid gland, adult	10199-103F1	53.03	2.47	0.62	1.23	0.00	0.00
penis, adult	10200-103F2	96.68	4.83	2.15	2.15	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	23.80	0.00	0.93	0.56	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	35.11	1.02	0.29	0.44	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	110.30	3.23	1.94	0.65	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	136.80	1.18	1.18	0.59	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	95.94	3.76	0.00	1.25	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	80.94	2.02	1.01	1.01	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	138.11	1.04	1.04	0.52	0.52	1.04
pituitary gland, adult, donor10258	10378-105G9	76.61	2.55	0.00	0.00	0.85	0.85
placenta, adult, pool1	10021-101D3	58.16	1.29	0.75	0.22	0.00	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	20.79	0.93	0.13	0.00	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.52	0.62	0.00	0.16	0.00	0.16
pons, adult, pool1	10033-101E6	92.95	3.61	1.98	0.26	1.38	0.86
postcentral gyrus, adult, pool1	10032-101E5	65.21	0.87	2.18	0.09	0.52	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	110.84	14.64	6.27	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	38.45	1.17	0.00	0.44	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	84.94	3.63	0.18	0.36	0.36	0.18
prostate, adult, pool1	10022-101D4	77.54	3.36	2.00	0.27	0.36	0.18
putamen, adult, donor10196	10176-103C5	73.18	0.94	3.07	0.71	0.71	0.24
putamen, adult, donor10252	10152-102I8	76.47	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	45.90	1.09	2.19	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	45.66	1.93	2.66	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	37.48	4.50	0.00	0.75	5.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	36.66	1.45	0.29	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	108.50	8.35	2.78	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	55.76	5.09	0.42	0.21	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	42.25	0.41	0.41	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	89.96	3.78	1.19	0.10	1.09	0.00
retinoblastoma cell line:Y79	10475-106I7	53.78	0.52	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.61	0.61	0.00	0.00	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	72.27	0.56	0.00	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	72.75	3.03	0.76	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	47.26	3.56	0.81	0.81	0.16	0.49
salivary acinar cells, donor2	11772-123I8	48.74	4.13	0.69	0.28	0.41	0.28
salivary acinar cells, donor3	11773-123I9	80.77	5.96	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	66.92	1.14	0.57	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	190.88	26.81	1.01	0.93	1.60	1.43
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	172.45	24.92	1.41	0.71	1.53	1.41
seminal vesicle, adult	10201-103F3	74.07	4.23	1.06	0.00	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	100.09	18.71	1.46	2.43	1.94	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	21.14	1.76	0.25	0.00	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	48.17	2.01	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	33.04	2.15	0.00	0.40	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	66.21	2.43	1.77	0.11	0.00	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	86.58	7.74	0.65	0.26	0.00	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	134.77	13.48	0.00	0.00	2.13	0.71
skeletal muscle, adult, pool1	10023-101D5	92.71	3.72	0.12	0.12	0.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	46.23	2.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	115.35	13.57	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	82.69	4.42	1.26	2.52	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	67.04	2.33	0.33	0.33	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	63.67	1.58	0.95	0.95	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	31.42	0.00	1.73	0.00	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	51.76	0.16	0.16	0.00	0.00	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	42.30	0.48	0.32	0.48	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	81.28	4.14	1.09	0.65	0.00	0.22
small intestine, adult, pool1	10024-101D6	147.99	24.13	1.19	0.36	0.24	1.07
small intestine, fetal, donor1	10064-101I1	70.51	4.18	0.49	0.74	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	27.18	3.08	0.00	1.54	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	86.32	1.29	0.78	1.29	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	44.76	2.41	0.27	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	113.79	4.59	1.38	3.21	2.06	0.23
spinal cord, adult, donor10252	10159-103A6	101.33	2.76	2.76	1.58	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	68.49	6.23	2.08	0.69	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	93.91	4.88	2.44	1.22	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	75.31	7.35	0.46	0.00	4.13	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	102.91	9.56	0.15	0.00	0.00	0.30
spleen, adult, pool1	10025-101D7	88.88	5.84	1.98	0.11	1.21	0.22
spleen, fetal, pool1	10044-101F8	85.49	3.81	2.38	0.24	1.11	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	57.45	3.83	0.41	0.31	0.52	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	76.52	2.28	0.76	0.00	0.38	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	63.60	4.19	1.75	1.40	2.80	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	140.34	37.14	1.17	1.56	0.39	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	36.02	1.69	0.34	0.11	0.34	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.23	1.69	0.00	0.00	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	44.00	1.69	0.00	0.00	0.85	0.42
stomach, fetal, donor1	10062-101H8	126.02	6.41	3.20	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	83.17	2.85	0.57	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	97.21	3.32	1.87	1.66	1.87	0.21
substantia nigra, adult, donor10258	10371-105G2	54.83	4.14	2.59	0.00	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	80.55	12.01	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	43.79	2.06	0.92	0.00	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	46.71	0.85	2.03	0.17	0.00	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	90.46	0.00	8.55	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	78.68	0.88	9.67	0.44	0.00	0.88
tenocyte, donor1	11763-123H8	56.21	3.14	0.00	0.70	0.00	0.35
tenocyte, donor2	11765-123I1	48.07	5.34	0.38	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	65.24	5.19	0.74	2.59	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	78.35	1.70	0.17	0.68	0.17	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	57.81	1.54	0.15	0.46	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	52.38	1.24	0.15	0.31	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.71	1.02	0.00	0.00	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	57.86	1.89	0.00	0.00	0.00	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	46.90	1.20	0.22	0.00	0.11	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	51.46	1.30	0.33	3.26	0.00	0.00
testis, adult, pool1	10026-101D8	104.47	2.47	0.97	1.07	1.72	9.88
testis, adult, pool2	10096-102C6	168.71	3.16	4.06	4.96	1.80	23.01
thalamus - adult, donor10196	10168-103B6	117.02	7.73	2.21	0.00	2.21	0.00
thalamus, adult, donor10252	10154-103A1	118.46	2.34	2.19	1.41	1.25	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	112.39	13.86	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	46.94	4.61	1.98	0.49	0.66	0.82
thalamus, newborn, donor10223	10366-105F6	39.12	9.21	1.15	0.00	3.45	1.15
throat, adult	10209-103G2	88.88	7.99	2.75	0.25	0.75	0.25
throat, fetal, donor1	10061-101H7	57.59	2.44	1.22	0.00	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	28.02	0.00	3.38	0.00	0.20	0.20
thymus, adult, pool1	10027-101D9	47.42	0.50	0.40	0.10	0.70	0.10
thymus, fetal, pool1	10043-101F7	82.19	2.18	0.94	0.00	0.42	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	49.99	5.32	0.53	0.40	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	67.05	2.79	1.54	0.14	0.14	0.28
thyroid, adult, pool1	10028-101E1	85.66	1.77	1.68	0.28	0.09	0.28
thyroid, fetal, donor1	10060-101H6	69.61	2.37	1.32	1.32	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	117.03	12.32	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	91.40	17.21	1.40	1.40	0.23	0.00
tongue, fetal, donor1	10059-101H5	72.51	6.31	0.79	1.18	0.79	0.00
tonsil, adult, pool1	10047-101G2	91.96	6.41	1.90	0.10	0.30	0.20
trachea, adult, pool1	10029-101E2	61.35	2.13	0.90	0.33	0.25	0.08
trachea, fetal, donor1	10058-101H4	76.55	3.85	1.15	0.77	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	78.29	5.31	0.35	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	46.91	0.91	0.30	0.10	0.00	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	63.30	1.57	0.16	0.63	0.16	0.63
tridermal teratoma cell line:HGRT	10694-109G1	39.95	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	38.60	1.02	0.51	0.08	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	54.25	4.17	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	120.98	9.21	5.12	0.00	1.19	0.68
uterus, fetal, donor1	10055-101H1	103.41	24.06	2.05	1.54	0.51	0.00
vagina, adult	10204-103F6	58.80	0.65	1.94	0.65	0.00	0.00
vein, adult	10191-103E2	56.77	1.32	0.22	0.44	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.17	0.27	0.27	0.27	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000496825.2:-265 ENST00000438374.5:-372 ENST00000490597.5:-423 BC017703:-425 ENST00000440230.5:-429 BC053668:-438 ENST00000483306.2:-448 NR_145514.2:-448 ENST00000421276.6:-458 AK291514:-458 ENST00000354379.8:-481 NM_001348300.1:-481 NM_001348303.1:-481 NM_001348302.1:-481 NM_001348306.1:-481 NM_001348310.1:-481 NM_001348309.1:-481 NM_001348311.1:-481 NM_001348298.1:-481 NM_001348297.1:-481 NM_001348299.1:-481 NM_001348301.1:-481 NM_001348305.1:-481 NM_001134369.2:-481 NM_001348304.1:-481 NM_001348308.1:-481 NM_017724.2:-481" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.